Ackrose Pharmaceuticals Private Limited
About Ackrose Pharmaceuticals Private Limited
Data last updated:
Ackrose Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51101DL2014PTC273152. Its GSTIN is 07AANCA0176B1Z0 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Puneet Gond and Vinod Kumar Gond.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 20/420 Ground Floor Laxmi Vihar Burari, Delhi, India – 110084.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.44 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹56,434 (net margin 1.9%) and EBITDA of ₹3.36 Lakh (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 14% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address20/420 Ground Floor Laxmi Vihar Burari, Delhi, India – 110084
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ackrose Pharmaceuticals Private Limited
The main business activity of Ackrose Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ackrose Pharmaceuticals Private Limited FY 2025 filings available
Ackrose Pharmaceuticals Private Limited reported revenue of ₹30.44 Lakh (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ackrose Pharmaceuticals Private Limited
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ackrose Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹3.36 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹56,434 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ackrose Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ackrose Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medchem Life Sciences Private Limited | ₹30.55 Lakh (FY 2024) | •••• | •••• | 376.0% | •••• | Hyderabad, Telangana, India |
| N.B. Life Science Private Limited | ₹30.53 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Hyderabad, Telangana, India |
| Sanghamitra Enterprises Private Limited | ₹30.53 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Bhubaneswar, Odisha, India |
| Therabimb Lifesciences Private Limited | ₹30.5 Lakh (FY 2024) | •••• | •••• | -44.0% | •••• | Navi Mumbai, Maharashtra, India |
| Keryx Pharmaceuticals Private Limited | ₹30.46 Lakh (FY 2025) | •••• | •••• | 33.0% | •••• | Mohali, Punjab, India |
| Ackrose Pharmaceuticals Private Limited this company | ₹30.44 Lakh (FY 2025) | •••• | •••• | -35.0% | •••• | Delhi, India |
| Bioclinical Pharmaceuticals Private Limited | ₹30.41 Lakh (FY 2022) | •••• | •••• | 47.0% | •••• | Pune, Maharashtra, India |
| Strebi Pharmaceuticals Private Limited | ₹30.4 Lakh (FY 2025) | •••• | •••• | -59.0% | •••• | Jagadhari, Haryana, India |
| Emryn Health Care Private Limited | ₹30.39 Lakh (FY 2025) | •••• | •••• | 56.0% | •••• | Sanand, Gujarat, India |
| Rimedile Pharmaceutical Private Limited | ₹30.32 Lakh (FY 2024) | •••• | •••• | 72.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Asthev Healthcare Private Limited | ₹30.32 Lakh (FY 2025) | •••• | •••• | 40.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Ackrose Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals Private Limited is audited by NIKHIL GOYAL & COMPANY for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIKHIL GOYAL & COMPANY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Puneet Gond | Director | 13 Nov 2014 | 11 Years 10 Months | Current |
| Vinod Kumar Gond | Director | 13 Nov 2014 | 11 Years 10 Months | Current |
Ownership and Shareholding of Ackrose Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ackrose Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2022 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ackrose Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ackrose Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Puneet Gond was appointed as Director on 13 Nov 2014.
Credit Ratings, Litigation & Regulatory Alerts for Ackrose Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ackrose Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ackrose Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AANCA0176B1Z0 | Delhi | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ackrose Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ackrose Pharmaceuticals Private Limited
Ackrose Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 November 2014 (12+ years old) and is registered under CIN U51101DL2014PTC273152.
Ackrose Pharmaceuticals reported revenue of ₹30.44 Lakh for FY 2025 (down 35% YoY).
Ackrose Pharmaceuticals has 2 current directors:
- Puneet Gond - Director
- Vinod Kumar Gond - Director
Ackrose Pharmaceuticals reported a net profit of ₹56,434 (net margin 1.9%) and EBITDA of ₹3.36 Lakh (EBITDA margin 11%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ackrose Pharmaceuticals is -15% over three years and 14% over five years. In the latest year (FY 2025) revenue fell 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ackrose Pharmaceuticals is 07AANCA0176B1Z0, registered in Delhi.
The CIN (Corporate Identification Number) of Ackrose Pharmaceuticals is U51101DL2014PTC273152. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ackrose Pharmaceuticals was incorporated on 13 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ackrose Pharmaceuticals by revenue are Medchem Life Sciences Private Limited, N.B. Life Science Private Limited, Sanghamitra Enterprises Private Limited, Therabimb Lifesciences Private Limited, Keryx Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Puneet Gond was appointed as Director on 13 Nov 2014. Vinod Kumar Gond was appointed as Director on 13 Nov 2014.
The registered office of Ackrose Pharmaceuticals is at 20420 Ground Floor Laxmi Vihar Burari, Delhi, India – 110084.